Login

Simeon Iheagwam's solo-GP fund supporting amazing founders|Simeon Iheagwam,Founder and Managing Partner,NOEMIS Ventures 00:10:00

Share On Facebook Share On Twitter

Founder & Managing Partner at NOEMIS Ventures

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Assembled a team of senior operators and investors|Arra Malekzadeh,Partner,Craft Ventures
00:10:00
Frank Tang on Economic Revival and Growth Prospects | Frank Tang, CEO, FountainVest Partners.
00:10:00
What is the Endowment Investment Philosophy | Prateek Mehrotra, CIO , Endowment Wealth Management.
00:10:00
Attracting and Retaining Talent Through Employee Benefits
00:10:00
Brad Rourke, President & CEO, Scotty Resources: Advancing Exploration in BC's Golden Triangle
00:10:00
Roberto Funari, on International Expansion, Digitalization, and Innovation | Roberto Funari, CEO , Alpargatas SA.
00:10:00
Ed invests in developer tools, SaaS, cybersecurity, and data infrastructure|Ed Sim,General Partner, Boldstart Ventures
00:10:00
Navigating Market Dynamics: Factors Influencing Business Outlook and Growth Prospects |Rafael Pérez , CFO, Befesa SA.
00:10:00
Daniel Tuffen Discusses Panther Metals' Exploration Focus on Nickel, Cobalt, and Gold in Western Australia
00:10:00
Mangold Insight interviews tech company DLTx, delving into discussions on AI competitiveness with a reference to C3.ai.
00:10:00
Unlocking the Secrets of Cybersecurity Entrepreneurship|Zane Lackey,General Partner,Andreessen Horowitz
00:10:00
A Discussion on Interest Rates, Credit Quality, and Sector Consolidation | Carlo Messina, CEO, Intesa Sanpaolo.

© 2017 - Neuhu+